Stay updated on Niraparib Combo vs Abiraterone in Metastatic Prostate Clinical Trial
Sign up to get notified when there's something new on the Niraparib Combo vs Abiraterone in Metastatic Prostate Clinical Trial page.

Latest updates to the Niraparib Combo vs Abiraterone in Metastatic Prostate Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedLatest version adds a 'Study Status' entry and updates revision metadata (Revision: v3.3.3, 2025-12-22). The earlier revision removed the 'HHS Vulnerability Disclosure' link (2025-11-13, Revision: v3.3.2).SummaryDifference0.2%

- Check20 days agoNo Change Detected
- Check27 days agoNo Change Detected
- Check34 days agoChange DetectedThe page history shows the addition of Revision: v3.3.2 and the removal of Revision: v3.3.1 in the footer. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check42 days agoChange DetectedRevision: v3.3.1 was added and Revision: v3.2.0 was removed from the Record History. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check49 days agoChange DetectedAdded a dedicated 'Study Status' section to display current recruitment status and removed the site-wide funding notice.SummaryDifference0.4%

- Check63 days agoChange DetectedA new version entry appears in the Record History page, indicating a recent update to the study record. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check92 days agoChange DetectedUpdated to v3.2.0 and added a government funding/operating-status notice; removed the old v3.1.0 reference.SummaryDifference8%

Stay in the know with updates to Niraparib Combo vs Abiraterone in Metastatic Prostate Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Niraparib Combo vs Abiraterone in Metastatic Prostate Clinical Trial page.